Drug Shortage Report for EDARBYCLOR

Last updated on 2019-01-23 History
Report ID 58987
Drug Identification Number 02397749
Brand name EDARBYCLOR
Common or Proper name EDARBYCLOR
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) CHLORTHALIDONE Azilsartan Medoxomil
Strength(s) 12.5MG 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size NA
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-11-28
Estimated end date
Actual end date 2019-01-22
Shortage status Resolved
Updated date 2019-01-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2019-01-23 French Compare
v16 2019-01-23 English Compare
v15 2019-01-10 French Compare
v14 2019-01-10 English Compare
v13 2018-12-21 French Compare
v12 2018-12-21 English Compare
v11 2018-12-14 French Compare
v10 2018-12-14 English Compare
v9 2018-12-02 English Compare
v8 2018-10-19 French Compare
v7 2018-10-19 English Compare
v6 2018-09-10 French Compare
v5 2018-09-10 English Compare
v4 2018-09-10 French Compare
v3 2018-09-10 English Compare
v2 2018-08-24 French Compare
v1 2018-08-24 English Compare

Showing 1 to 17 of 17